CARFILNAT 60mg Vial contains the active substance Carfilzomib. It belongs to a group of medicines known as Proteasome Inhibitors. It is primarily indicated for the treatment of Multiple Myeloma, a type of blood cancer that affects plasma cells in the bone marrow. Carfilzomib may be used alone or in combination with other anticancer medicines such as dexamethasone and lenalidomide.
Carfilzomib works by blocking proteasomes, which are structures inside cells responsible for breaking down unwanted proteins. This causes toxic proteins to accumulate within cancer cells, leading to their destruction and slowing the progression of the disease.
CARFILNAT 60mg Vial should only be administered under the supervision of an oncologist or qualified healthcare professional experienced in cancer treatment.
Uses of CARFILNAT 60mg Vial
- Treatment of Multiple Myeloma
- Relapsed Multiple Myeloma
- Refractory Multiple Myeloma
- Combination therapy with dexamethasone
- Combination therapy with lenalidomide and dexamethasone
- Long-term management of plasma cell malignancies
Therapeutic Effects of CARFILNAT 60mg Vial
CARFILNAT 60mg Vial exerts its therapeutic effect by selectively inhibiting proteasome activity within cancer cells. This prevents the breakdown of damaged proteins, leading to protein accumulation, cellular stress, and programmed cancer cell death (apoptosis). This helps reduce tumor burden and slows disease progression.
Interaction of CARFILNAT 60mg Vial with Other Drugs
It is important to inform your healthcare professional about all medicines you are taking, including prescription medications, supplements, and herbal products.
Notable interactions include:
-
Dexamethasone: Commonly used in combination therapy.
-
Lenalidomide: Frequently prescribed alongside Carfilzomib.
-
Antiviral Medicines: May be prescribed for infection prevention.
-
Blood Pressure Medications: Monitoring may be required.
-
Other Chemotherapy Agents: Increased risk of toxicity and side effects.
More Information about CARFILNAT 60mg Vial
- Keep out of reach of children and pets.
- Store in a refrigerator between 2°C and 8°C.
- Do not freeze.
- Protect from direct sunlight.
- Store in the original packaging until use.
How to Consume CARFILNAT 60mg Vial
CARFILNAT 60mg Vial is administered as an intravenous (IV) infusion by a qualified healthcare professional in a hospital or clinical setting.
The dosage and treatment schedule depend on the patient's body surface area, medical condition, previous therapies, and treatment response. Do not self-administer this medicine. Adequate hydration is often recommended before and during treatment.
Safety Advice for CARFILNAT 60mg Vial
Breast Feeding
Unsafe / Contraindicated
Breastfeeding should be avoided during treatment as Carfilzomib may harm the infant.
Alcohol
Caution
Alcohol may worsen fatigue, dizziness, and other treatment-related side effects.
Liver
Caution
Patients with liver disease should be closely monitored during therapy.
Kidneys
Caution
Kidney function should be monitored regularly, especially in patients with pre-existing kidney impairment.
Driving
Caution
CARFILNAT may cause dizziness, weakness, fatigue, or low blood pressure. Avoid driving if affected.
Pregnancy
Unsafe / Contraindicated
Carfilzomib may cause serious fetal harm. Effective contraception should be used during treatment.
Side Effects of CARFILNAT 60mg Vial
Side effects are unwanted symptoms caused by medicines. Although not everyone experiences them, some patients may develop side effects.
Common Side Effects of CARFILNAT 60mg Vial
- Fatigue
- Nausea and vomiting
- Fever
- Diarrhea
- Shortness of breath
- Anemia
- Low platelet count
- Weakness
Serious Side Effects of CARFILNAT 60mg Vial
- Heart failure
- High blood pressure
- Severe infections
- Kidney failure
- Liver toxicity
- Tumor Lysis Syndrome
- Severe breathing difficulties
- Blood clot formation
Word of Advice
Patients receiving CARFILNAT 60mg Vial require regular monitoring of blood counts, kidney function, liver function, and cardiovascular health. Adequate hydration before treatment can help reduce the risk of kidney-related complications. Report symptoms such as chest pain, shortness of breath, rapid weight gain, severe fatigue, fever, or unusual bleeding immediately to your healthcare provider.
FAQs about CARFILNAT 60mg Vial
Q1. What is CARFILNAT 60mg Vial used for?
It is primarily used for the treatment of relapsed or refractory Multiple Myeloma.
Q2. How does CARFILNAT work?
It blocks proteasomes inside cancer cells, causing toxic protein buildup and cancer cell death.
Q3. Is CARFILNAT chemotherapy?
CARFILNAT is a targeted anticancer therapy known as a proteasome inhibitor rather than traditional chemotherapy.
Q4. Why is hydration important during treatment?
Adequate hydration helps reduce the risk of kidney complications and tumor lysis syndrome.
Q5. Can CARFILNAT be used with other cancer medicines?
Yes. It is commonly used in combination with dexamethasone and lenalidomide-based treatment regimens.
Fact Box of CARFILNAT 60mg Vial
Molecule Name: Carfilzomib 60mg
Therapeutic Class: Antineoplastic Agents
Pharmacological Class: Proteasome Inhibitors
Indications: Multiple Myeloma, Relapsed Multiple Myeloma, Refractory Multiple Myeloma, Combination Anticancer Therapy.
